Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

New study finds potential link between GLP1 agonists and depression, urging further investigation into patient safety.

Employers face rising GLP-1 demand. Here are tips to manage costs while maintaining care access.

A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...

In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval ...

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and ...

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...